• Search results for Covishield
Image Title
delhi-masks-759

Students wanting to study abroad in a fix as India's vaccines remain unrecognised in some countries 

Many fear that the new variant possibly evades existing vaccines. While vaccine makers have said that the vaccines can be tweaked to fight the 'Omicron', it will take months for them to develop it

Published on 27th November 2021
COVID-19-Vaccine-6-3

Between Covishield and Covaxin, centre has created two classes of citizens, says Kerala High Court

The court said that in case the Centre wants more time to make a decision, a direction can be issued to pay the petitioner the amount he received as salary while working abroad

Published on 2nd November 2021
Vaccine_RGGH_EPS

COVID-19: Andhra Pradesh government to vaccinate people in 18-45 age group by first week of October 

About 9 lakh doses of Covishield and Covaxin were kept ready before commencing vaccination for the 18-45 age group

Published on 24th August 2021
COVID-19-Vaccine-6-3

Mixing Covishield and Covaxin can yield better results against COVID, says ICMR's new study

The study was conducted on individuals in Uttar Pradesh who received Covishield as the first dose followed by inadvertent administration of Covaxin as the second dose at an interval of six weeks

Published on 8th August 2021
Covishield_(1)

India pushes Italy to recognise CoWIN certificate for Covishield

Italy is not on the list of countries that have given a "green pass" to the Astra-Zeneca vaccine manufactured by the Serum Institute of India 

Published on 10th July 2021
Covishield

After Switzerland, Iceland and others, Netherlands becomes latest EU country to approve Covishield

People who have been fully vaccinated can be exempted from the EU entry ban unless they are travelling from a country that has been designated as a very high-risk area due to the presence of a variant

Published on 2nd July 2021
Covishield

Serum Institute requests government to get Covishield included in EU COVID-19 Vaccination Passport

Only four vaccines — Comirnaty of Pfizer/BioNTech, Moderna, Vaxzevria by AstraZeneca-Oxford and Johnson & Johnson's Janssen — have been approved by the European Medicines Agency (EMA) 

Published on 28th June 2021
vaccine-5873170_1920

Delhi government sets up vaccine centre for people travelling abroad for studies, work

The centre has been set up at the Navyug School on Mandir Marg. Those who wish to avail of the facility will have to carry their passports and relevant travel documents

Published on 14th June 2021
vaccine-5873170_1920

Mumbai students travelling abroad for studies express happiness over prioritised vaccination 

Students said that it was a huge support amid the struggle to book a vaccination appointment when the slots are gone within a minute

Published on 11th June 2021
What_the_FAQs_1

What The FAQ: Going abroad to study or work? All you need to know about speeding up your vax jab

The Union Health Ministry has said that those travelling abroad for education, employment or as part of the Tokyo Olympic representation will be vaccinated ASAP

Published on 8th June 2021
What_the_FAQs_(1)

What the FAQ: What is Corbevax? Why is it important for India?

The government had recently placed an order for 30 crore doses of a vaccine called Corbevax. We explain all about it here

Published on 7th June 2021
Proper-storage-temperature-is-crucial-to-vaccine-potency

National Technical Advisory Group on Immunisation recommends 12-16 week gap between Covishield doses, no change for Covaxin

These recommendations will be sent to NEGVA — the National Expert Group on Vaccine Administration - for approval before the changes and suggestions are implemented

Published on 13th May 2021
Covishield

Govt has released full advance for Covishield vaccine to SII on April 28: Health Ministry

Additionally, 100 per cent advance of Rs 787.50 crore (after TDS Rs 772.50 crore) was released on April 28 to Bharat Biotech India Ltd (BBIL) for five crore Covaxin doses during May, June and July

Published on 3rd May 2021
Pfizer-BioNTech_COVID-19_vaccine_(2020)_C

Government asks Serum Institute, Bharat Biotech to lower the price of COVID-19 vaccines: Official sources

The Hyderabad-based Bharat Biotech has fixed the price of its COVID-19 vaccine, Covaxin, at Rs 600 per dose for state governments and at Rs 1,200 per dose for private hospitals

Published on 27th April 2021
vaccine

Serum prices COVID vaccine for Pvt hospitals at Rs 600/dose, for state govt at Rs 400/dose 

SII said the Covishield vaccine will be available to state governments for Rs 400 per dose and to private hospitals at Rs 600 per dose

Published on 21st April 2021

Search results 1 - 15 of 18